Benralizumab: First Global Approval. [electronic resource]
- Drugs Mar 2018
- 505-511 p. digital
Publication Type: Journal Article; Review
1179-1950
10.1007/s40265-018-0876-8 doi
Administration, Inhalation Anti-Asthmatic Agents--administration & dosage Antibodies, Monoclonal, Humanized--administration & dosage Asthma--drug therapy Drug Approval Humans Interleukin-5 Receptor alpha Subunit--immunology Male Pulmonary Disease, Chronic Obstructive--drug therapy Pulmonary Eosinophilia--drug therapy Treatment Outcome United States United States Food and Drug Administration